MapLight Therapeutics, Inc.

NASDAQ: MPLT · Healthcare · Biotechnology

PublicHQ Redwood City, CA · San MateoCIK 0001770069Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 58DQ —GM —SS 49

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$161.2M

Employees

133

as of 2026-08-20

Market cap

$515.6M

as of 2026-08-20

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$161.2M-$161.2M2025

Operating income-$169.1M-$169.1M2025

Total assets$479.5M$479.5M2025

Liabilities$21.1M$21.1M2025

Equity$458.4M$458.4M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is MapLight Therapeutics, Inc.’s financial profile?

MapLight Therapeutics, Inc. earned -$161.2M in FY2025 net income.

Peers · Healthcare

GMR Solutions Inc.——Odyssey Therapeutics, Inc.——Zura Bio Limited——Nuvectis Pharma, Inc.——Eikon Therapeutics, Inc. Common Stock——Kyverna Therapeutics, Inc.——

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B86A Gilead Sciences, Inc.$29.4B87A Equinix, Inc.$9.2B74B Robinhood Markets, Inc.$4.5B67B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$053D

Key facts

CEOChristopher A. Kroeger

SectorHealthcare

IndustryBiotechnology

HeadquartersRedwood City, CA

ExchangeNASDAQ: MPLT

Employees133

IPO date2025-10-24

Latest filings

8-K2026-08-13 10-Q2026-08-13 8-K2026-07-27 8-K2026-06-24 8-K2026-06-22 8-K2026-06-18 8-K2026-05-14 10-Q2026-05-14

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.